The synovial interface: At the intersection from cells to humans.

The synovium is increasingly recognized as a dynamic interface that integrates immunological, mechanical, sensory, and anatomical signals within the joint. In inflammatory rheumatic and musculoskeletal diseases, synovial inflammation represents not only a biological process driven by immune-synovial stromal interactions, but also a clinical construct shaped by the perception of both the patient and the health care professional (HCP), both in terms of physical findings and patient- and HCP reported outcomes, as well as laboratory- or imaging-based interpretation. Despite major advances in understanding the cellular and molecular mechanisms of synovitis, the reliable detection and monitoring of synovial inflammation in clinical practice remains challenging. Clinical joint assessment shows only moderate reliability and limited agreement with patient-reported findings, while pain and tenderness frequently reflect factors beyond active inflammation, including existing structural damage, central sensitization and comorbidities. Imaging modalities such as ultrasound and magnetic resonance imaging have substantially improved the visualization of synovitis and joint damage, increasing measurement reliability and construct validity. However, imaging-guided treat-to-target strategies have not consistently translated into superior clinical outcomes, highlighting a persistent gap between improved detection and effective therapeutic decision-making. This perspective frames the synovium as a multidimensional interface at the intersection of biology, anatomy, perception, and technology. By integrating evidence from cellular models, clinical examination, imaging studies, and emerging monitoring strategies, we propose that future progress in inflammatory arthritis will depend on hybrid approaches that move beyond single modalities toward interface-based assessment of disease activity.